The value of an acute octreotide suppression test in predicting short-term efficacy of somatostatin analogues in acromegaly-Reference-Cited by-同舟云学术

The value of an acute octreotide suppression test in predicting short-term efficacy of somatostatin analogues in acromegaly

Published:2016 Issue:9 Volume:63 Page:819-834
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Wang Meng¹²,Shen Ming³⁴,He Wenqiang³,Yang Yeping¹,Liu Wenjuan¹,Lu Yun⁵,Ma Zengyi³,Ye Zhao³,Zhang Yichao³,Zhao Xiaolong¹⁴,Lu Bin¹⁴,Hu Ji²,Huang Yun²,Shou Xuefei³⁴,Wang Yongfei³⁴,Ye Hongying¹⁴,Li Yiming¹⁴,Li Shiqi³⁴,Zhao Yao³⁴,Zhang Zhaoyun¹⁴

Affiliation:

1. Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China

2. Division of Endocrinology, the Second Affiliated Hospital, Soochow University, Suzhou 215000, China

3. Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China

4. Shanghai Pituitary Tumor Center, Shanghai 200040, China

5. Department of Nuclear Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/63/9/63_EJ16-0175/_pdf

Reference34 articles.

1. 1. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, et al. (2011) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update. Endocr Pract 17 Suppl 4: 1-44.

2. 2. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, et al. (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83: 3411-3418.

3. 3. Bates AS, Van’t Hoff W, Jones JM, Clayton RN (1993) An audit of outcome of treatment in acromegaly. Q J Med 86: 293-299.

4. 4. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, et al. (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94: 1509-1517.

5. 5. Melmed S, Jackson I, Kleinberg D, Klibanski A (1998) Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 83: 2646-2652.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of biochemical response to somatostatin receptor ligands in acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

2. Personalized Medicine in Acromegaly: The ACROFAST Study;The Journal of Clinical Endocrinology & Metabolism;2024-06-29

3. Germline AIP variants in sporadic young acromegaly and pituitary gigantism: clinical and genetic insights from a Han Chinese cohort;Endocrine;2024-06-08

4. New molecular tools for precision medicine in pituitary neuroendocrine tumors;Minerva Endocrinology;2024-01

5. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly;Archives of Medical Research;2023-12